Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Personalis (NASDAQ:PSNL) through any online brokerage.
Other companies in Personalis’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Personalis has a consensus price target of $12.65.
The stock price for Personalis (NASDAQ: PSNL) is $15.85 last updated October 13, 2026 at 3:08 PM EDT.
There are no upcoming dividends for Personalis.
Personalis does not have any upcoming earnings scheduled.
There is no upcoming split for Personalis.
Personalis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.